STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details Narrative) - USD ($)								1 Months Ended	3 Months Ended		6 Months Ended
	Jun. 22, 2020	Jun. 18, 2020	May 27, 2020	Apr. 16, 2020	Feb. 27, 2020	Jan. 31, 2020	Nov. 14, 2017	Jan. 31, 2020	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2013	Dec. 17, 2003
Option, expense									$ 267,865	$ 126,077	$ 485,470	$ 249,788
Unrecognized compensation cost											$ 131,362
Weighted average vest term											6 months
Value of shares issued									$ 9,447	$ 15,000	$ 17,181	$ 15,000
Over-Allotment Option [Member]
Shares issued during period (in shares)		50,000
Number of warrant issued		325,987
Warrant [Member] | Over-Allotment Option [Member]
Exercise price (in dollars per share)	$ 4.60
Warrant term	5 years
Number of warrant issued	2,499,900
Warrant [Member] | Common Stock [Member]
Description of conversion stock	Company cancelled the 2020 Warrants for twenty-three of the twenty-five warrant holders and issued to the holders of the cancelled warrants an aggregate of 179,200 shares of Common Stock. Of this amount, 33,000 shares of Common stock were issued to four directors and an entity in which one officer of the Company is a majority owner and co-manager. 2020 Warrants to purchase an aggregate of 81,700 shares of Common Stock at an exercise price of $4.59 per share remain outstanding. Also on such date, the 2020 Debentures were automatically converted into an aggregate of 637,513 shares of common stock and warrants to purchase 573,479 shares of common stock. Of this amount, 105,567 shares of common stock and warrants to purchase 105,567 of shares of common stock were issued to four directors and an entity in which one officer of the Company is a majority owner and co-manager.
Warrant [Member] | Common Stock [Member]
Description of conversion stock	the per share exercise price for the outstanding but unexercised 2020 Warrants to purchase shares of common stock related to the two warrant holders who did not cancel their 2020 Warrants, has been adjusted from $7.50 to $4.59 and the number of shares of common stock underlying the outstanding but unexercised 2020 Warrants increased from an aggregate of 50,000 to 81,700 shares of common stock.
Convertible Debt [Member]
Description of conversion stock						(i) the commencement of trading of the common stock on the NASDAQ, New York Stock Exchange or NYSE American (an “Uplist”) at the Uplist Conversion Price (defined below); or (ii) at any time the minimum bid price of the common stock exceeded $25.00 per share for twenty (20) consecutive trading days and the average trading volume during the 10 trading days prior to the conversion was at least 2,000 shares and the shares were registered under an effective registration statement or the shares were salable under Rule 144 (“Rule 144”) of the Securities Act of 1933, as amended.
Convertible Debt [Member] | Warrant [Member] | Over-Allotment Option [Member]
Shares issued during period (in shares)	173,913
Shares issued during period	$ 522,515
Exercise price (in dollars per share)	$ 5.06
Warrant term	3 years
Warrant [Member]
Exercise price (in dollars per share)									$ 3.81		$ 3.81
Warrant [Member] | Convertible Debt [Member]
Warrant amount									$ 82,500		$ 82,500
Chief Operating Officer [Member]
Granted											1,000,000
Four Director [Member]
Shares issued during period (in shares)								40,000
Shares issued during period								$ 137,160
Expiration date								Jan. 07, 2025
Exercise price (in dollars per share)						$ 3.505		$ 3.505
Five Director [Member]
Term of unvested options								1 year
Shares issued during period (in shares)								50,000
Shares issued during period								$ 171,451
Expiration date								Jan. 07, 2025
Exercise price (in dollars per share)						3.505		$ 3.505
Chief Executive Officer (Patrick White) [Member]
Shares issued during period				$ 153,913
Expiration date				Aug. 15, 2025
Warrant term				3 years
Number of shares issued for services (in shares)				140,000
Mr. Gardner [Member]
Expiration date				Jun. 29, 2025
Number of shares issued for services (in shares)				90,000
Value of shares issued				$ 53,913
Director [Member]
Shares issued during period				$ 11,811
Expiration date				Apr. 16, 2025
Exercise price (in dollars per share)				$ 4.025
Number of shares issued for services (in shares)				3,000
Director [Member] | Warrant [Member] | Common Stock [Member]
Description of conversion stock	Warrants to purchase 448,000 shares of common stock were cancelled (including 2020 Warrants for 82,500 shares that had been issued to four directors and an entity in which one officer of the Company is a majority owner and co-manager) and warrants to purchase 573,479 shares of common stock were issued upon closing of the Offering and conversion of the 2020 Debentures, with an exercise price of $4.60 and an expiration term of five years. Of this amount, warrants to purchase 105,567 of shares of common stock were issued to four directors and an entity in which one officer of the Company is a majority owner and co-manager.
Two Director [Member]
Shares issued during period			$ 41,435
Expiration date			May 27, 2025
Exercise price (in dollars per share)			$ 5.295
Number of shares issued for services (in shares)			8,000
Four Non - Employees Member [Member]
Shares issued during period			$ 53,835
Expiration date			May 27, 2023
Exercise price (in dollars per share)			$ 5.295
Number of shares issued for services (in shares)			11,000
Chief Operating Officer [Member]
Term of unvested options								1 year
Shares issued during period (in shares)								4,000
Shares issued during period								$ 13,716
Expiration date								Jan. 07, 2025
Exercise price (in dollars per share)						$ 3.505		$ 3.505
Four Directors And One Officer [Member] | Convertible Debt [Member]
Exercise price (in dollars per share)					$ 7.50
Warrant term					3 years
Number of shares issued for services (in shares)					498,000
Employee Stock Option [Member]
Exercise price, description											In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).
Granted											105,000
Stock Option 2003 Plan [Member]
Number of shares authorized to be granted under plan														360,000
Stock Option 2003 Plan [Member] | Stock Options, Restricted Stock and Units, and Other Stock-based Awards [Member]
Number of shares authorized to be granted under plan													400,000
Equity Incentive Plan 2017 [Member] | Board of Director [Member]
Shares issued during period (in shares)							260,000